Increasingly potent immunosuppressive agents have dramatically reduced the incidence of
rejection of transplanted organs while increasing susceptibility to opportunistic infections …

A primary goal in organ transplantation is the prevention or effective treatment of infection,
the most common life-threatening complication of long-term immunosuppressive therapy …

Reactivation of human cytomegalovirus (HCMV) results in severe disease in AIDS patients
and immunocompromised patients receiving blood transfusions or organ or bone marrow …

Background The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients
has resulted in the frequent use of prophylaxis with the aim of preventing the clinical …

In the past three decades since the inception of human organ transplantation,
cytomegalovirus (CMV) has gained increasing clinical import because it is a common …

We have previously demonstrated reactivation of latent human cytomegalovirus (HCMV) in
myeloid lineage cells obtained from healthy donors. Virus was obtained from allogenically …

At a time when the judicious use of a broad range of immunosuppressive drugs has ensured
excellent patient and organ survival rates after kidney transplantation, attention is focusing …

Objective: The goal of this meta‐analysis was to investigate the impact of cytomegalovirus
hyperimmune globulin (CMVIG) on cytomegalovirus (CMV) infection, CMV disease, and mid …

We studied the incidence, trends and clinical correlates of infections following kidney
transplantation in the United States Renal Data System over the years 1995–2003 in 46,471 …

Background Cytomegalovirus (CMV) is a significant cause of morbidity and mortality in solid
organ transplant recipients. Pre‐emptive treatment of patients with CMV viraemia using …